Precision Medicine for Localized Prostate Cancer: Time to Move Beyond NCCN Risk Stratification?
Int J Radiat Oncol Biol Phys
.
2019 Jan 1;103(1):92-94.
doi: 10.1016/j.ijrobp.2018.09.040.
Epub 2018 Dec 12.
Authors
Zachary S Zumsteg
1
,
Daniel E Spratt
2
Affiliations
1
Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
2
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: sprattda@med.umich.edu.
PMID:
30563670
DOI:
10.1016/j.ijrobp.2018.09.040
No abstract available
Publication types
Editorial
Comment
MeSH terms
Genomics
Humans
Male
Precision Medicine
Prostatic Neoplasms*
Radiotherapy, Image-Guided*